The future of diabetes management: expanding access to and impact of CGM for patients with type 2 diabetes

The article explores how expanding access to continuous glucose monitoring (CGM) for individuals with type 2 diabetes—especially those not using insulin—can lead to improved clinical outcomes and reduced healthcare costs. It presents peer-led best practices and underscores the value of integrating CGM into primary care, supported by real-world evidence. It highlights some of the latest evidence highlighting CGM’s benefits in lowering emergency department visits and optimizing medication use, while advocating for broader coverage and streamlined access to diabetes technology.